This study investigates advanced solid tumors. It evaluates the effects of local infusion of checkpoint inhibitors combined with a chemotherapeutic drug.
The study focuses on assessing the safety and effectiveness of this treatment approach. It evaluates how well the treatment works and its impact on patient outcomes.
- Who can participate: Adults over 18 with advanced solid tumors and an estimated survival over 3 months may participate. Participants must meet specific health criteria and be willing to follow the study schedule.
- Study details: Participants will receive investigational medication through local infusion. Some will receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand